CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer

Paul A. Cohen, M.L. Friedlander, Val Gebski et al.|Annals of Oncology|2025

Cited by 0